APPLICATION
ANDA216599
TYPE
ANDA
ORIGINAL APPROVAL
2022-10-24
LATEST ACTION
2026-01-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 100MG BASE · TABLET · ORAL
Approval history
2026-01-26Labeling · Supplement 4 · standardAP
2025-09-30Labeling · Supplement 3 · standardAP
2025-03-31Labeling · Supplement 2 · standardAP
2022-10-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.